RNAi Developer Dicerna Pharmaceuticals to IPO

RNA Interference (RNAi) is a new approach in the development of specific targeted therapies against both...

Nano Drug Delivery with Oasmia

In a previous article, we discussed Bind Therapeutics, a company developing a nano-drug delivery technology for Docetaxel,...

Nanotherapeutics – Nanotechnology and Homeland Defense

In previous articles, we have discussed the potential of nanotechnology-enabled drug delivery systems such as...